Skip to main content

Bulldog Bio to Market Dualsystems' Protein Expression Wares in the US

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bulldog Bio this week announced a deal to sell Dualsystems Biotech's protein expression and analysis systems and products in the US.

Bulldog Bio said the deal is a "long-term relationship," and makes it the single source of all Dualsystems' products in the US, but it didn't provide any additional terms of the deal.

Dualsystems is a contract research organization based in Zurich, Switzerland and provides yeast two-hybrid screening services and products and other technologies for protein-related research, as well as custom cDNA library construction services, according to its website.

Bulldog is based in Portsmouth, NH, and provides laboratory products to life science researchers.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.